References
- Melkle A W., Smith J A. Epidemiology of prostatic cancer. Urol Clin North Am 1990; 17: 709–18
- Johansson J E., Adami H O., Andersson S O., et al. Natural history of localized prostatic cancer: a population-based study in 223 untreated patients. Lancet 1989; 1: 799–803
- Pontes J E., Wajsman Z, Huben R P., et al. Prognostic factors in localized prostatic carcinoma. J Urol 1985; 134: 1137–9
- Stamey T A., McNeal J E., Freiha F S., et al. Morphometry and clinical studies on 68 consecutive radical prostatectomies. J Urol 1988; 139: 1235–41
- Bostwick D G., Graham S D., Napalkov P, et al. Staging of early prostatic cancer: a proposed tumor volume-based prognostic index. Urology 1993; 41: 403–11
- Epstein Jl, Oesterling J E., Walsh P C. The volume and anatomical location of residual tumor in radical prostatectomy specimens removed for stage A1 prostate cancer. J Urol 1988; 139: 975
- Enlund A, Pedersen K V., Boeryd B, et al. Transrectal ultrasonography compared to histopathological assessment for local staging of prostatic carcinoma. Acta Radiol 1990; 31: 597–600
- Ritchie A WS, Dorey F, Layfleld L J., et al. Relationship of DNA content to conventional prognostic factors in clinically localised carcinoma of the prostate. Br J Urol 1988; 62: 254–60
- Hussein A A., Nagel R. Nuclear DNA analysis: ONA heterogeneity in the monitoring of patients with locally advanced prostatic carcinoma. Eur Urol 1992; 22: 303–10
- Paulson D F., Stone A R., Walther P J., Tucker J A., Cox E B. Radical prostatectomy: anatomical predictors of success of failure. J Urol 1986; 136: 1041–3
- Rannikko S, Salo J O. Radical prostatectomy as treatment of localized prostatic cancer. Scand J Urol Nephrol 1990; 24: 103–7
- Splgelman S S., McNeal J E., Freiha F S., Stamey T A. Rectal examination in volume determination of carcinoma of the prostate: clinical and anatomical correlations. J Urol 1986; 136: 1228–30
- Pontes J E., Eisenkraft S, Watanabe H, Ohe H, Saitoh M, Murphy G P. Preoperative evaluation of localized prostatic carcinoma by transrectal ultrasonography. J Urol 1985; 134: 289–91
- Salo J O., Klvlsaari L, Rannikko S, Lehtonen T. Computerized tomography and transrectal ultrasound in the assessment of local extension of prostatic cancer before radical retropubic prostatectomy. J Urol 1987; 137: 435–8
- Lee F, Torp-Pedersen S T., Slders D B., Littrup P J., McLeary R D. Transrectal ultrasound in the diagnosis and staging of prostatic carcinoma. Radiology 1989; 170: 609
- Schnall M D., Lenkinski R E., Pollack H M., Imal Y, Kressel H Y. Prostate: MR imaging with endorectal surface coil. Radiology 1989; 172: 570
- Schnall M D., Connlck E, Hayes C E., Lenkinski R E., Kressel H Y. Imaging of the pelvis with endorectal-external multi coil assay. J Mag Res Imag 1992; 2: 229–32
- Parr R D., Andrus C, Boullier J. Staging laparoscopic pelvic lymph node dissection: comparison of results with open pelvic lymphadenectomy. J Urol 1992; 147: 875–8
- Wolf J S., Jr, Shlnohara K, Kerlikowske K M., Narayan P, Stoller M L., Carroll P R. Selection of patients for laparoscopic pelvic lymphadenectomy prior to radical prostatectomy: a decision analysis. Urology 1993; 42: 680–8
- Cooper E H., Robinson M RG, Whelan P, Ferro M A. Tumor markers in prostate cancer. Cancer 1992; 70: 225–9
- Pantelides M L., Bowman S P., George N JR. Levels of prostate specific antigen that predict skeletal spread in prostate cancer. Br J Urol 1992; 70: 299–303
- Oesterling J E., Martin S K., Bergstralh E J., Lowe F C. The use of prostate-specific antigen in staging patients with newly diagnosed prostate cancer. JAMA 1993; 269: 57–60
- Sasslne A M., Schulman C. Clinical use of prostate-specific antigen in the staging of patients with prostatic carcinoma. Eur Urol 1993; 23: 348–51
- Pedersen K V. Localized carcinoma of the prostate. Aspects on screening, staging and surgical treatment. Lind-köping University Medical Dissertations No 377, Lindköping. 1993
- Walsh P C., Lepor H, Eggleston J C. Radical prostatectomy with preservation of sexual function: anatomical and pathological considerations. Prostate 1983; 4: 473–85
- Igel T C., Barret D M., Segura J W., Van den Rife C C. Perioperative and postoperative complications from bilateral pelvic lymphadenectomy and radical retropubic prostatectomy. J Urol 1987; 137: 1189–91
- Ritchie A WS, James K, deKernion J B. Early postoperative morbidity of total prostatectomy. Br J Urol 1989; 64: 511–5
- Boxer R J., Kaufman J J., Goodwin W E. Radical prostatectomy for carcinoma of the prostate: 1951-1976. A review of 329 patients. J Urol 1977; 117: 208–13
- Schellhammer P F., Whitmore R B., Kuban D A., El-Mahdi A M., Ladaga L A. Morbidity and mortality of local failure after definitive therapy for prostate cancer. J Urol 1989; 141: 567–71
- Gibbons R P., Correa R J., Branen G E., Weissman R M. Total prostatectomy for clinically localized prostatic cancer: long term results. J Urol 1989; 141: 564–6
- Middleton R G., Larsen R H. Selection of patients with stage B prostate cancer for radical prostatectomy. Urol Clin North Am 1990; 17: 779–85
- Bagshaw M A. Potential for radiotherapy alone in prostate cancer. Cancer 1985; 55: 2079–85
- Hanks G E., Diamond J J., Krall J M., Martz K L., Kramer S. A 10-year follow-up of 682 patients treated for prostate cancer with radiation therapy in the United States. Int J Radiat Oncol Biol Phys 1987; 13: 499–505
- Lerner S P., Seale-Hawkins C, Carlston C E., Scardino P T. The risk of dying of prostate cancer in patients with clinically localized disease. J Urol 1991; 146: 1040–51
- George N JR. Natural history of localised prostatic cancer managed by concervative therapy alone. Lancet 1988; 494–7
- Whitmore W F., Warner J A., Thompson I M. Expectant management of localized prostatic cancer. Cancer 1991; 67: 1091–6
- Johansson J E., Van den Andersson S O., Bergström R, Holmberg L, Krusemo U B. High 10-year survival rate in patients with early, untreated prostatic cancer. JAMA 1992; 267: 2191–6
- Adolfsson J, Carstensen J, Löwhagen T. Deferred treatment in clinically localised prostatic carcinoma. Br J Urol 1992; 69: 183–7
- Paulson D F., Lin G H., Hinshaw W, Stephanl S, the Uro-oncology Research Group. Radical surgery versus radiotherapy for adenocarcinoma of the prostate. J Urol 1982; 128: 502–4
- Byar D P., Corle D K. VACURG randomized trial of radical prostatectomy for stages I and II prostate cancer. Urology 1981; 17: 7
- Hfnman F, Jr. A point of view. Screening for prostatic carcinoma. J Urol 1991; 146: 126–30
- Haas G P., Montie J E., Pontes J E. The state of prostate cancer screening in the United States. Eur Urol 1993; 23: 337–47